In light of the strong desire to shorten timelines and lower cost for biologics such as monoclonals specially biosimilars, and address surging demand for complex proteins such as bispecific antibodies ...
Transcenta Therapeutics, a global biopharmaceutical company with capabilities in discovery, research, development and ...
About Transcenta Therapeutics Transcenta (HKEX: 06628) is a global clinical stage biopharmaceutical company with fully integrated capabilities in antibody-based biotherapeutics discovery, research, ...
Pharmaceutical manufacturing steps are often isolated in space and time. The synthesis, isolation and purification of the drug substance (DS) and the formulation of the drug product (DP) may be ...
SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced today that it has ...
Before the advent of biologics, commercialization of a therapeutic relied on successfully scaling up to meet market demand. This scaling-up strategy expanded biomanufacturing capacity by upsizing the ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)-- C3 AI (NYSE: AI), the Enterprise AI application software company, today announced that Genentech, the medical biotechnology company, has selected C3 AI ...
DUBLIN--(BUSINESS WIRE)--The "Biologics Contract Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System ...
Transcenta inks strategic collaboration and non-exclusive licensing pact with EirGenix to advance integrated continuous biomanufacturing and expand global access to affordable biologics Princeton, New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback